See All Slides - tctmd.com

Slides

Presentation THT Abstracts 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation THT Abstracts 2025

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation THT Abstracts 2025

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT Abstracts 2025

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Disparities in MDD Incidence Between HFpEF and HFrEF Patients

Presenter: Ibrahim Kamel

February 11, 2025

Presentation THT Abstracts 2025

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Presenter: Emmanuel Otabor

February 11, 2025

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

Advertisement

Slides

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Disparities in MDD Incidence Between HFpEF and HFrEF Patients

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content